Louisville, Ky., Feb. 12, 2016 – Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new
By Varun Saxena, FierceMedicalDevices December 10, 2015 – Harpoon Medical Executive Vice President Peter Boyd told FierceMedicalDevices that cardiology titan Edwards Lifesciences acquired an option
By Varun Saxena, FierceMedicalDevices December 9, 2015 – Just as the flurry of M&A activity in the transcatheter mitral valve repair arena appears to be
Glasgow, United Kingdom, November 4th 2015 – Caldan Therapeutics Ltd (Caldan) has announced a £4.45 million ‘Series A’ investment led by Epidarex Capital, a leading
Outstanding clinical results reported at 2015 Transcatheter Therapeutics Conference in San Francisco. Baltimore, MD, Oct. 15, 2015 – Harpoon Medical, Inc. a medical device company
By Zach Kaufman, Medgadget The device, produced by Baltimore-based Harpoon Medical, seeks to provide another in a series of recent improvements in mitral valve repair
Edinburgh, United Kingdom, 16th September, 2015 – Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could
The company has also received $1.4M of a $2M bridge round to accelerate its clinical program Baltimore, MD, Sept. 15, 2015 – Harpoon Medical, a
Edinburgh, United Kingdom, 2nd September 2015 – The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans
Crestwood, KY – July 15, 2015 – Apellis Pharmaceuticals, Inc., a clinical stage complement immunotherapy company, announced today the formation of a Scientific Advisory Board